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Dear Editor,
Li et al. [2] presented the pooled results of randomized con-
trolled trials and concluded that probiotic administration in-
creases the H pylori eradication rate and reduces the risk of
therapy-related side effects.
It is tempting to produce a single estimate of the treatment
effect of probiotics. However, pooling data from different
strains and doses of probiotics obtained in different settings
and/or populations may result in misleading conclusions. The
risk is that the results could be erroneously extrapolated to
other probiotics. This concern is shared bymany experts in the
field of probiotics [1, 3, 4].
In settings where there are tens of different probiotic
products available, one wants to know the efficacy of
one specific probiotic, not of probiotics in general. The
meta-analysis by Li et al. does not help to resolve such
uncertainty.
What could be the solution? One approach could be to
perform a meta-analysis that evaluates the effect of adminis-
tering a clearly defined, probiotic(s). In children, for there is
no single probiotic that has been studied in more than one
RCT. With a lack of repeat studies, can we be sure that all or
any probiotic(s) studied are really effective?
In my opinion, those of us who are working in the probiotic
field should avoid pooling data on different probiotics.
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